“…Recently, efficient genome editing by the CRISPR-Cas9 system has been demonstrated in multiple organisms, including human, mouse, rat, zebrafish, Drosophila and C. elegans (Cong et al, 2013;Friedland et al, 2013;Gratz et al, 2013;Hou et al, 2013;Hwang et al, 2013;Jinek et al, 2013;Li et al, 2013;Mali et al, 2013b;Yang et al, 2013). In contrast to previous genome-editing techniques, such as zinc-finger nucleases (ZFNs) (Meng et al, 2008;Gupta et al, 2011;Chu et al, 2012;Enuameh et al, 2013) and transcription activator-like effector nucleases (TALENs) , the target specificity of CRISPRCas9 is primarily dictated by a Watson-Crick pairing of a 20-base sequence at the 5′-end of the sgRNA with the target site instead of protein-DNA recognition, providing a much easier system to target multiple genes simultaneously. It has been shown that compared with ZFNs and TALENs, CRISPR-Casmediated gene targeting has similar or greater efficiency in human cells, zebrafish and metazoan Nematostella vectensis (Ding et al, 2013;Ikmi et al, 2014;Smith et al, 2014).…”